Related Experiment Video
Updated: Jun 19, 2026
23:06
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
Quality DOTS management and empowering tuberculosis patients
1NWG, IMA GFATM RNTCP PPM Project.
Journal of the Indian Medical Association
|October 9, 2009
Summary
The Central TB Division covers India with DOTS, a program partnered by IMA under RNTCP. This article discusses innovations for tuberculosis control in India, adhering to international care standards.
Area of Science:
- Public Health
- Infectious Disease Control
Background:
- The Central Tuberculosis Division (CTD) has implemented Directly Observed Treatment, Short-course (DOTS) across India.
- The Indian Medical Association (IMA) partners with the Revised National Tuberculosis Control Program (RNTCP), managed by CTD.
- International Standards for Tuberculosis Care are essential for all healthcare providers.
Purpose of the Study:
- To elaborate on International Standards for quality management in tuberculosis control.
- To discuss necessary innovations for DOTS in the Indian context.
- To highlight IMA's commitment to tuberculosis containment in India.
Main Methods:
- Review of existing tuberculosis control strategies and standards.
- Discussion of program implementation through sensitization and district training.
- Analysis of partnership between IMA and RNTCP for DOTS expansion.
Main Results:
- DOTS/DMC centers have been established in target states through training programs.
- The IMA GFATM RNTCP PPM program is completing two years.
- The article outlines key aspects of International Standards for Tuberculosis Care.
Conclusions:
- India has achieved nationwide DOTS coverage through CTD.
- Innovations are needed to optimize DOTS delivery within the Indian healthcare system.
- Continued commitment and adherence to international standards are crucial for tuberculosis elimination.
Related Concept Videos
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:26Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:28Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:31Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
01:23Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...